ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

Show other versions (1)

<p class="MsoNormal" style="margin: 0cm 0cm 0pt; line-height: 200%;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><span lang="EN-US">Allogeneic conventional hemato...

Full description

Bibliographic Details
Published in:	Mediterranean Journal of Hematology and Infectious Diseases
Main Authors:	Mohamed L. Sorror, Rainer F. Storb
Format:	Article
Language:	English
Published:	PAGEPress Publications 2010-05-01
Subjects:	Myelodysplasia , Hemopoietic Stem Cell Transplantation, Risk Factors
Online Access:	http://www.mjhid.org/article/view/6042

Similar Items

ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
by: Mohamed L. Sorror, et al.
Published: (2010-06-01)

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
by: Guru Subramanian Guru Murthy, et al.
Published: (2024-01-01)

TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
by: Silvia F Costa, et al.
Published: (2013-11-01)

ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Angelo Michele Carella
Published: (2012-10-01)

Successful Treatment of Lomentospora Prolificans Infection Following Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review
by: Yang YH, et al.
Published: (2025-07-01)

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND SOLUTIONS
by: Hossam Kamel Mahmoud, et al.
Published: (2020-04-01)

PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
by: Suparno Chakrabarti, et al.
Published: (2009-12-01)

PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
by: Somnath Mukherjee, et al.
Published: (2009-11-01)

HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
by: Mario Pani, et al.
Published: (2009-06-01)

HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
by: Emanuele Angelucci, et al.
Published: (2009-06-01)

The effectiveness of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in the treatment
by: T. V. Yukhta, et al.
Published: (2019-12-01)

Sexual development and gonads function in children and adolescents after allogeneic stem cell transplantation using different conditioning regimes
by: L. I. Papusha, et al.
Published: (2022-11-01)

Parotiditis associated with parainfluenza virus type 3 infection in an autologous stem cell transplantation patient.
by: silvia F costa
Published: (2014-08-01)

Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy
by: Gianluca Cavallaro
Published: (2024-04-01)

Features of transfusion therapy in patients undergoing hematopoietic stem cell transplantation. Review of the literature
by: D. N. Balashov, et al.
Published: (2014-07-01)

The prognostic value of posttransplant chimerism
by: A. A. Sipol, et al.
Published: (2022-11-01)

Stem Cell Transplantation for Ovarian Cancer Patient with Associated Myelodysplasia After Maintenance Therapy with Olaparib: A Case Report
by: Linn Z, et al.
Published: (2025-02-01)

Role of high-dose chemotherapy with hemopoietic stem cell transplantation in patients with non-Hodgkin's lymphomas
by: V. V. Ptushkin, et al.
Published: (2022-11-01)

Simultaneous myelodisplasia and multiple myeloma successfully treated with lenalidomide
by: Alessandro Gozzetti, et al.
Published: (2014-08-01)

Kidney Transplantation After Allogeneic Hematopoietic Cell Transplantation
by: Marie-Julia Ziliotis, et al.
Published: (2024-04-01)

Storage of hemopoietic stem cells
by: Pamphilon Derwood, et al.
Published: (2007-01-01)

Evaluation of the efficacy of autologous hematopoietic stem cell transplantation combined with intermittent low dose cyclophosphamide in the treatment of severe lupus nephritis
by: ZHANG Su-yang, et al.
Published: (2019-01-01)

The impact of viral infections on the results of hemopoietic stem cell transplantation in patients with hematologic malignancies
by: T. V. Antonova, et al.
Published: (2021-01-01)

Optimizing Timing and Preparation for Allogeneic Hematopoietic Stem Cell Transplantation in Higher-Risk Myelodysplastic Syndromes
by: Geng L, et al.
Published: (2025-08-01)

Bilateral Vocal Cord Palsy with Arnold Chiari Malformation: A Rare Case Series
by: Nikhil Arora, et al.
Published: (2016-09-01)

Nonmyeloablative allogeneic hematopoietic cell transplantation
by: Rainer Storb, et al.
Published: (2016-05-01)

Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation
by: D. S. Dubnyak, et al.
Published: (2022-12-01)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
by: Elena Kum, et al.
Published: (2021-01-01)

New Insights on Iron Study in Myelodysplasia
by: Noha M. El Husseiny, et al.
Published: (2014-12-01)

Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of Tunisia
by: Leila Achour, et al.
Published: (2023-12-01)

Hereditary spherocytic hemolytic anemia in an adult with the formation of ectopic foci of extramedullary hemopoiesis in the chest
by: A L Melikyan, et al.
Published: (2010-07-01)

Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Venous Thromboembolism after Allogeneic Pediatric Hematopoietic Stem Cell Transplantation: A Single-Center Study
by: Fatih Azık, et al.
Published: (2015-07-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
by: Mohammad Faizan Zahid, et al.
Published: (2014-12-01)

Progenitor Cell Function and Cardiovascular Remodelling Induced by SGLT2 Inhibitors
by: Theodora M. Stougiannou, et al.
Published: (2024-04-01)

Prognostic factors of the efficiency of obtaining the autologous precursor cells of hemopoiesis for further transplantation after large-dose chemotherapy: review of literature and the authors' data
by: A. Yu. Popov, et al.
Published: (2022-11-01)

Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review
by: Olivia F. Lynch, et al.
Published: (2022-02-01)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
by: Reena V. Jayani, et al.
Published: (2021-03-01)

Bloodstream infections in different stage of reconstitution after first allogeneic hematopoietic stem cell transplantation
by: M. I. Akhmedov, et al.
Published: (2022-01-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)